<DOC>
	<DOCNO>NCT02534493</DOCNO>
	<brief_summary>A single-center , prospective , non-randomized study evaluate safety efficacy novel carpal tunnel tissue manipulation device treat symptom decrease physical function subject previously diagnose mild severe carpal tunnel syndrome ( CTS ) .</brief_summary>
	<brief_title>Safety Efficacy Novel Carpal Tunnel Tissue Manipulation Device Treating Carpal Tunnel Syndrome</brief_title>
	<detailed_description>A single-center , prospective , non-randomized study evaluate safety efficacy novel carpal tunnel tissue manipulation device treat symptom decrease physical function subject previously diagnose mild severe carpal tunnel syndrome .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Carpal Tunnel Syndrome</mesh_term>
	<criteria>Inclusion Criteria 1. male female , age 2165 good general health ; 2. subject diagnose mild severe carpal tunnel syndrome ( CTS ) ( AANEM criterion CTS ) mild CTS : prolonged distal sensory latency ± decrease sensory amplitude moderate CTS : abnormal median sensory latency prolongation distal motor latency severe CTS : prolonged motor sensory distal peak latency either low absent SNAP CMAP 3. bilateral CTS accept ( either mild , moderate severe CTS bilaterally ) , however , involved wrist ( via NCS ) use `` study '' wrist ; 4 . Boston Carpal Tunnel Questionnaire ( BCTQ ) Symptoms Score ≥ 2 ; 5. woman childbearing potential must willing practice effective contraception duration study ( i.e. , abstinence , condom diaphragm spermicide , IUD , birth control pills [ BCP ] ) ; NOTE : Females birth control pill ( BCP ) must stable type dose pill least three month prior enter study must change type BCP dose regimen study . Those discontinue use BCPs favor another form contraception must discontinue BCP usage least 3 month prior start study . 6. woman child bear potential must negative urine pregnancy test Baseline Visit ( Visit 1 , Day 0 ) must lactate ; 7. willingness follow protocol requirement , include signing informed consent health information release form , attend routine followup visit complete questionnaire . Exclusion Criteria 1. know sensitivity adhesives glue ; 2. history diabetes mellitus ; 3. history thyroid disease ; 4. history prior wrist fracture ; 5. know easily bruise ( hematoma ) ; 6. concurrent use blood thinner ; 7. history connective tissue disease ; 8. diagnose superimpose peripheral neuropathy ; 9. history cervical radiculopathy ; 10. diagnose purely ulnar paresthesia ; 11. history ulnar neuropathy ; 12. history brachial plexopathy ; 13. diagnose pronator teres syndrome ; 14. history polyneuropathy ; 15. uncontrolled systemic disease ; 16. history mass , tumor , severe trauma deformity hand wrist ; 17. previous surgery hand wrist ; 18. history prior carpal tunnel release ; 19. current use splint brace medical device CTS ; 20. currently take medication therapy could cause focal generalize neuropathy ( e.g. , antiepileptic , statin , chemotherapeutic antiarrhythmic ) ; 21. history systemic disease clinical evidence condition would make subject , opinion investigator , unsuitable study could potentially confound study result ; 22. concomitant use systemic medication ( ) therapy may substantial effect CTS condition , unless medication ( ) therapy has/have use minimum 3 month prior study enrollment , is/are expect remain constant throughout course study is/are consider necessary subject ' welfare ; 23. female pregnant , nursing , plan pregnancy childbearing potential use reliable method contraception ; 24. inability give informed consent ; 25. concurrent participation prior participation investigation drug device study within last 30 day prior Baseline Visit ( Visit 1 ) .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>